Level of 8-OHdG in drained dialysate appears to be a marker of peritoneal damage in peritoneal dialysis
- PMID: 22334795
- PMCID: PMC3278254
- DOI: 10.2147/IJNRD.S27553
Level of 8-OHdG in drained dialysate appears to be a marker of peritoneal damage in peritoneal dialysis
Abstract
Purpose: Peritoneal dialysis (PD) is a successful renal replacement therapy; however, long-term PD leads to structural and functional peritoneal damage. Therefore, the monitoring and estimation of peritoneal function are important in PD patients. Oxidative stress has been implicated as one possible mechanism of peritoneal membrane damage. The aim of this study was to evaluate the association between an oxidative stress marker, 8-hydroxydeoxyguanosine (8-OHdG), and peritoneal damage in PD patients.
Methods: The authors evaluated 8-OHdG in drained dialysate by enzyme immunoassay to investigate the association between 8-OHdG and solute transport rate estimated by peritoneal equilibration test and matrix metalloproteinase-2 (MMP-2) level in 45 samples from 28 PD patients.
Results: The 8-OHdG level was significantly correlated with dialysate:plasma creatine ratio (r = 0.463, P < 0.05) and significantly inversely correlated with D/D0 glucose (where D is the glucose level of peritoneal effluents obtained 4 hours after the injection and D0 is the glucose level obtained immediately after the injection) (r = -0.474, P < 0.05). The 8-OHdG level was also significantly correlated with MMP-2 level (r = 0.551, P < 0.05), but it was not correlated with the age of subjects, the duration of PD, or blood pressure.
Conclusion: The level of 8-OHdG in drained dialysate may be a useful novel marker of peritoneal damage in PD.
Keywords: MMP-2; oxidative stress; peritoneal equilibration test; solute transport rate.
Figures



Similar articles
-
Matrix metalloproteinase levels in the drained dialysate reflect the peritoneal solute transport rate: a multicentre study in Japan.Nephrol Dial Transplant. 2011 May;26(5):1695-701. doi: 10.1093/ndt/gfq593. Epub 2010 Oct 4. Nephrol Dial Transplant. 2011. PMID: 20921293
-
The association between soluble intercellular adhesion molecule-1 levels in drained dialysate and peritoneal injury in peritoneal dialysis.Ren Fail. 2017 Nov;39(1):392-399. doi: 10.1080/0886022X.2017.1287735. Ren Fail. 2017. PMID: 28201944 Free PMC article. Clinical Trial.
-
The potential of matrix metalloproteinase-2 as a marker of peritoneal injury, increased solute transport, or progression to encapsulating peritoneal sclerosis during peritoneal dialysis--a multicentre study in Japan.Nephrol Dial Transplant. 2007 Feb;22(2):560-7. doi: 10.1093/ndt/gfl566. Epub 2006 Oct 11. Nephrol Dial Transplant. 2007. PMID: 17035369
-
The relationship between ultrafiltrate volume with icodextrin and peritoneal transport pattern according to the peritoneal equilibration test.Perit Dial Int. 2002 Mar-Apr;22(2):229-33. Perit Dial Int. 2002. PMID: 11990408
-
Dialysate copeptin and peritoneal transport in incident peritoneal dialysis patients.Int Urol Nephrol. 2019 Sep;51(9):1667-1673. doi: 10.1007/s11255-019-02191-5. Epub 2019 Jun 11. Int Urol Nephrol. 2019. PMID: 31187425 Free PMC article.
Cited by
-
The Behavior of the Type of Peritoneal Transport in the Inflammatory and Oxidative Status in Adults Under Peritoneal Dialysis.Front Med (Lausanne). 2019 Sep 27;6:210. doi: 10.3389/fmed.2019.00210. eCollection 2019. Front Med (Lausanne). 2019. PMID: 31612137 Free PMC article.
-
Oxidative stress and inflammation in hemodialysis: a comparison of patients with or without advanced nonalcoholic fatty liver disease (NAFLD).Ren Fail. 2025 Dec;47(1):2455523. doi: 10.1080/0886022X.2025.2455523. Epub 2025 Jan 22. Ren Fail. 2025. PMID: 39842820 Free PMC article.
-
Zinc supplementation alters plasma aluminum and selenium status of patients undergoing dialysis: a pilot study.Nutrients. 2013 Apr 22;5(4):1456-70. doi: 10.3390/nu5041456. Nutrients. 2013. PMID: 23609777 Free PMC article. Clinical Trial.
-
The Role of Oxidative Stress in Kidney Injury.Antioxidants (Basel). 2023 Sep 16;12(9):1772. doi: 10.3390/antiox12091772. Antioxidants (Basel). 2023. PMID: 37760075 Free PMC article. Review.
-
Febuxostat for hyperuricemia in patients with advanced chronic kidney disease.Drug Target Insights. 2014 Aug 13;8:39-43. doi: 10.4137/DTI.S16524. eCollection 2014. Drug Target Insights. 2014. PMID: 25210423 Free PMC article.
References
-
- Krediet RT. Advances in peritoneal dialysis. Minerva Urol Nefrol. 2007;59(3):251–260. - PubMed
-
- Burkart J, Piraino B, Kaldas H, et al. Why is the evidence favoring hemodialysis over peritoneal dialysis misleading? Semin Dial. 2007;20(3):200–202. - PubMed
-
- Van Biesen W, Vanholder R, Lameire N. The role of peritoneal dialysis as the first-line renal replacement modality. Perit Dial Int. 2000;20(4):375–383. - PubMed
-
- Hung KY, Huang JW, Tsai TJ, Chen WY. Natural changes in peritoneal equilibration test results in continuous ambulatory peritoneal dialysis patients: a retrospective, seven year cohort survey. Artif Organs. 2000;24(4):261–264. - PubMed
-
- Williams JD, Craig KJ, Topley N, et al. Morphologic changes in the peritoneal membrane of patients with renal disease. J Am Soc Nephrol. 2002;13(2):470–479. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous